Radiation dosimetric and biodistribution comparison of the PSMA agonists 177Lu-PSMA I&T, 99mTc-Hynic PSMA and 99Tc-PSMA I&T to the 177Lu-RM2 antagonist

被引：0
|
作者：
Limouris, G. [1 ,2 ]
Paphiti, M. [3 ]
Zafeirakis, A. [2 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Sch Med, Nucl Med, Athens, Greece
[2] Army Share Fund Hosp Athens, Dept Nucl Med, Athens, Greece
[3] Pharmazac SA, Cyclotron Sect, Athens, Greece
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0071
引用
收藏
页码：S459 / S459
页数：1
相关论文
共 50 条
  • [31] Optimized sampling schedules for renal dosimetry of 177Lu-PSMA I&T regarding the hybrid planar-SPECT/CT method
    Rinscheid, A.
    Kletting, P.
    Allmann, J.
    Allmann, A.
    Eiber, M.
    Beer, A. J.
    Glatting, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S171 - S172
  • [32] Therapy of Metastasized Prostate Cancer Using a Lu-177 Labeled PSMA Inhibitor (I&T): First Dosimetric Results in Patients
    Schuchardt, C.
    Wiessalla, S.
    Ozkan, A.
    Kulkarni, H. R.
    Shahinfar, M.
    Sayeg, M.
    Weineisen, M.
    Wester, H. J.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S99 - S99
  • [33] Application of machine learning to pretherapeutically estimate dosimetry in men with advanced prostate cancer treated with 177Lu-PSMA I&T therapy
    Song Xue
    Andrei Gafita
    Chao Dong
    Yu Zhao
    Giles Tetteh
    Bjoern H. Menze
    Sibylle Ziegler
    Wolfgang Weber
    Ali Afshar-Oromieh
    Axel Rominger
    Matthias Eiber
    Kuangyu Shi
    European Journal of Nuclear Medicine and Molecular Imaging, 2022, 49 : 4064 - 4072
  • [34] Radiation dosimetry for 177Lu-PSMA I&T therapy in metastatic prostate cancer: results for normal organs, tumor lesions and comparison between different cycles
    Okamoto, Shozo
    Thieme, Anne
    Allmann, Jakob
    Maurer, Tobias
    Retz, Margitta
    Tauber, Robert
    Heck, Matthias
    Wester, Hans-Juergen
    Tamaki, Nagara
    Scheidhauer, Klemens
    Schwaiger, Markus
    Ziegler, Sibylle
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [35] Radioligand Treatment with [177Lu]Lu-PSMA I&T in the Older Patients - Safety, Efficacy, and Prognostic Factors for Survival
    Weber, Simon
    Seitz, Anna
    Kuebler, Hubert
    Buck, Andreas
    Werner, Rudolf
    Hartrampf, Philipp
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [36] Comparative Preclinical Biodistribution, Dosimetry, and Endoradiotherapy in Metastatic Castration-Resistant Prostate Cancer Using 19F/177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T
    Yusufi, Nahid
    Wurzer, Alexander
    Herz, Michael
    D'Alessandria, Calogero
    Feuerecker, Benedikt
    Weber, Wolfgang
    Wester, Hans-Juergen
    Nekolla, Stephan
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (08) : 1106 - 1111
  • [37] Voxel-wise Prediction of Post-therapy Dosimetry for 177Lu-PSMA I&T Therapy using Deep Learning
    Xue, Song
    Gafita, Andrei
    Afshar-Oromieh, Ali
    Eiber, Matthias
    Rominger, Axel
    Shi, Kuangyu
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [38] Lu-177 PSMA I&T Therapy for Prostate Cancer; Treatment Response, Treatment Toxicity, and Survival Results
    Acar, Emine
    Sonmezer, Burak
    Derebek, Erkan
    Bekis, Recep
    Ozdogan, Ozhan
    Kaya, Gamze Capa
    JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES, 2019, 3 (03): : 158 - 164
  • [39] Identification of [177Lu]Lu-PSMA I&T, [177Lu]LuCl3 and [177Lu] Lu-DTPA by a single reversed-phase TLC
    Cucchi, C.
    Bogni, A.
    Mainente, M.
    Beretta, C.
    Kirienko, M.
    Seregni, E.
    Pascali, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S666 - S666
  • [40] Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions
    Okamoto, Shozo
    Thieme, Anne
    Allmann, Jakob
    D'Alessandria, Calogero
    Maurer, Tobias
    Retz, Margitta
    Tauber, Robert
    Heck, Matthias M.
    Wester, Hans-Juergen
    Tamaki, Nagara
    Fendler, Wolfgang P.
    Herrmann, Ken
    Pfob, Christian H.
    Scheidhauer, Klemens
    Schwaiger, Markus
    Ziegler, Sibylle
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (03) : 445 - 450
12345